Genflow Biosciences Plc
Total Valuation
USDAs of December 31, 2025, Genflow Biosciences Plc carries a market capitalization of 17.73M, placing it among publicly traded companies globally. Its enterprise value stands at 17.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.73M |
| Enterprise Value | 17.58M |
Share Statistics
As of December 31, 2025, Genflow Biosciences Plc has 493.55M shares outstanding.
| Shares Outstanding | 493.55M |
Valuation Ratios
These figures are as of December 31, 2025.
| PB Ratio | -23.90 |
| P/TBV Ratio | -23.90 |
Financial Position
As of December 31, 2025, Genflow Biosciences Plc maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.45 |
| Quick Ratio | 0.11 |
Stock Price Statistics
USDAs of the close on October 21, 2026, Genflow Biosciences Plc's stock has gained approximately 80.00% over the past 52 weeks.
| 52-Week Price Change | 80.00% |
| 50-Day Moving Average | 0.04 |
Balance Sheet
USDThese figures are as of December 31, 2025. Total book value stands at -742,137.81, with working capital of -743,574.16 providing operational flexibility.
| Cash & Cash Equivalents | 150,630.59 |
| Net Debt | -150,630.59 |
| Equity (Book Value) | -742,137.81 |
| Working Capital | -743,574.16 |